Luis A Diaz Selected Research

Desmoglein 1

1/2022	From Insect Bites to a Skin Autoimmune Disease: A Conceivable Pathway to Endemic Pemphigus Foliaceus.
12/2020	A Lutzomyia longipalpis Salivary Protein Induces Cross-Reactive Antibodies to Pemphigus Autoantigen Desmoglein 1.
1/2018	Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope.
3/2016	Overlapping IgG4 Responses to Self- and Environmental Antigens in Endemic Pemphigus Foliaceus.
1/2015	Update on fogo selvagem, an endemic form of pemphigus foliaceus.
2/2014	Analysis of Anti-desmoglein 1 Autoantibodies in 68 Healthy Mother/Neonate Pairs from a Highly Endemic Region of Fogo Selvagem in Brazil.
11/2012	IgG autoantibody response against keratinocyte cadherins in endemic pemphigus foliaceus (fogo selvagem).
8/2012	Cutting Edge: Brazilian pemphigus foliaceus anti-desmoglein 1 autoantibodies cross-react with sand fly salivary LJM11 antigen.
4/2011	IgE, IgM, and IgG4 anti-desmoglein 1 autoantibody profile in endemic pemphigus foliaceus (fogo selvagem).
12/2009	Antigen selection of anti-DSG1 autoantibodies during and before the onset of endemic pemphigus foliaceus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luis A Diaz Research Topics

Disease

98	Neoplasms (Cancer) 01/2022 - 03/2004
35	Pemphigus (Pemphigus Vulgaris) 01/2022 - 05/2002
29	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 03/2004
16	Blister (Bulla) 01/2018 - 08/2002
15	Microsatellite Instability 04/2022 - 10/2016
15	Bullous Pemphigoid (Pemphigoid) 01/2018 - 10/2002
13	Skin Diseases (Skin Disease) 01/2022 - 05/2002
12	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 04/2005
11	Pemphigus and fogo selvagem 01/2018 - 08/2002
9	Adenocarcinoma 01/2022 - 07/2008
8	Melanoma (Melanoma, Malignant) 01/2021 - 04/2013
8	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018 - 02/2012
8	Acantholysis 06/2015 - 06/2005
6	Neoplasm Metastasis (Metastasis) 12/2019 - 03/2004
5	Disease Progression 12/2020 - 10/2007
5	Carcinogenesis 12/2018 - 08/2011
4	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2013
4	Turcot syndrome 01/2019 - 06/2015
4	Glioma (Gliomas) 07/2015 - 07/2012
4	Carcinoma (Carcinomatosis) 06/2015 - 10/2010
3	Rectal Neoplasms (Rectal Cancer) 01/2022 - 01/2012
3	Leishmaniasis 01/2022 - 12/2004
3	Fatigue 01/2022 - 01/2020
3	Infections 09/2020 - 10/2007
3	Colonic Neoplasms (Colon Cancer) 11/2017 - 06/2011
3	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 07/2013 - 10/2002
3	Brain Neoplasms (Brain Tumor) 04/2013 - 09/2008
2	COVID-19 11/2021 - 10/2020
2	Bites and Stings (Sting) 11/2021 - 12/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2018
2	Endometrial Neoplasms (Endometrial Cancer) 01/2018 - 01/2013
2	Inflammation (Inflammations) 01/2018 - 11/2006
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2016 - 12/2011
2	Residual Neoplasm 01/2016 - 01/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2014 - 03/2011
2	Lymphoma (Lymphomas) 04/2014 - 03/2011
2	Intellectual Disability (Idiocy) 04/2013 - 03/2011
2	Chagas Disease (American Trypanosomiasis) 10/2012 - 12/2004
1	Intestinal Perforation 01/2022
1	Colitis 01/2022
1	Neutropenia 01/2022

Drug/Important Bio-Agent (IBA)

41	AutoantibodiesIBA 01/2022 - 05/2002
28	Immunoglobulin G (IgG)IBA 01/2022 - 10/2002
26	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2005
23	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2009
20	Immune Checkpoint InhibitorsIBA 04/2022 - 09/2013
15	Desmoglein 1IBA 01/2022 - 08/2002
15	Proteins (Proteins, Gene)FDA Link 02/2018 - 10/2002
14	Cell-Free Nucleic AcidsIBA 01/2022 - 11/2005
14	AntibodiesIBA 01/2022 - 05/2002
10	AntigensIBA 12/2020 - 01/2006
9	Circulating Tumor DNAIBA 01/2018 - 09/2008
8	pembrolizumabIBA 01/2022 - 06/2015
7	Pharmaceutical PreparationsIBA 01/2021 - 05/2005
5	Monoclonal AntibodiesIBA 01/2022 - 06/2013
5	Cadherins (E-Cadherin)IBA 01/2018 - 06/2005
5	DesmogleinsIBA 06/2010 - 11/2006
4	Salivary Proteins and PeptidesIBA 01/2022 - 06/2010
4	Gemcitabine FDA Link 11/2021 - 02/2012
4	Cetuximab (Erbitux)FDA Link 01/2021 - 04/2013
4	p38 Mitogen-Activated Protein KinasesIBA 04/2011 - 11/2006
3	NivolumabIBA 01/2022 - 11/2016
3	Calcibiotic Root Canal SealerIBA 11/2021 - 01/2019
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 12/2012
3	Fluorouracil (Carac)FDA LinkGeneric 12/2020 - 03/2004
3	Biological ProductsIBA 12/2019 - 01/2012
3	LigandsIBA 01/2019 - 01/2006
3	Glycoproteins (Glycoprotein)IBA 01/2015 - 12/2010
3	Immunoglobulin M (IgM)IBA 04/2011 - 10/2002
2	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 11/2021 - 10/2020
2	Peptides (Polypeptides)IBA 01/2021 - 01/2009
2	VemurafenibIBA 01/2021 - 06/2013
2	AutoantigensIBA 12/2020 - 03/2016
2	PlatinumIBA 11/2020 - 09/2015
2	Lipase (Acid Lipase)FDA Link 01/2020 - 10/2007
2	Rituximab (Mabthera)FDA Link 03/2019 - 08/2007
2	AllergensIBA 01/2019 - 06/2012
2	Complement System Proteins (Complement)IBA 01/2019 - 11/2006
2	EpitopesIBA 01/2018 - 06/2003
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018 - 12/2005
2	Immunoglobulin E (IgE)IBA 01/2018 - 04/2011
2	Desmosomal CadherinsIBA 01/2017 - 11/2006
2	IpilimumabIBA 11/2016 - 09/2013
2	ErbB Receptors (EGF Receptor)IBA 10/2015 - 06/2013
2	ChromatinIBA 09/2014 - 07/2012
2	Indicators and Reagents (Reagents)IBA 01/2014 - 12/2013
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2013 - 04/2013
2	Carcinoembryonic AntigenIBA 12/2013 - 09/2009
2	Docetaxel (Taxotere)FDA Link 12/2012 - 02/2012
2	Desmoglein 3IBA 11/2012 - 12/2008
2	MicroRNAs (MicroRNA)IBA 08/2011 - 03/2006
2	Caspase 3 (Caspase-3)IBA 05/2009 - 01/2009
2	Liposomes (Liposome)IBA 10/2007 - 11/2006
1	Leishmaniasis VaccinesIBA 01/2022
1	Exonucleases (3' 5' Exonuclease)IBA 01/2022

Therapy/Procedure

43	Therapeutics 04/2022 - 10/2004
19	Drug Therapy (Chemotherapy) 01/2022 - 03/2004
16	Immunotherapy 04/2022 - 08/2014
3	Neoadjuvant Therapy 01/2022 - 07/2017